Hemophilia Quiz

Hemophilia: Practice Guide for Exam-Style Questions

Hemophilia is a classic topic in hematology that frequently appears on medical exams. Understanding its core pathophysiology, inheritance patterns, and clinical management is crucial. This guide breaks down the essential concepts to help you tackle related questions with confidence.

Core Definition: Clotting Factor Deficiency

At its heart, hemophilia is a genetic bleeding disorder caused by a deficiency or absence of a specific clotting factor protein. This impairs the intrinsic pathway of the coagulation cascade, preventing the formation of a stable fibrin clot and leading to prolonged bleeding.

Differentiating Hemophilia A vs. Hemophilia B

This is a common point of confusion. Hemophilia A is a deficiency of Factor VIII, while Hemophilia B is a deficiency of Factor IX. Though clinically indistinguishable, they are genetically distinct. Hemophilia A is far more common, accounting for about 80-85% of cases.

The Genetics: X-Linked Recessive Inheritance

Both Hemophilia A and B are X-linked recessive disorders. This means the responsible gene is on the X chromosome. Consequently, the condition predominantly affects males, who inherit the affected X chromosome from their carrier mothers. Females are typically asymptomatic carriers.

Clinical Manifestations: Joints, Muscles, and More

The hallmark of severe hemophilia is spontaneous bleeding, particularly into joints (hemarthrosis) and deep muscles. Repeated hemarthrosis can lead to debilitating chronic joint disease known as hemophilic arthropathy. Intracranial hemorrhage is the most feared and life-threatening complication.

Diagnosing Hemophilia: Key Lab Findings

Exam questions often present lab results. For hemophilia, you should look for a specific pattern: an isolated prolongation of the activated Partial Thromboplastin Time (aPTT), with a normal Prothrombin Time (PT), bleeding time, and platelet count. A definitive diagnosis requires specific factor assays.

• Prolonged aPTT: Reflects a problem in the intrinsic pathway (where factors VIII and IX act).
• Normal PT: Indicates the extrinsic pathway is intact.
• Normal Platelet Count: Rules out thrombocytopenia as the cause of bleeding.
• Normal Bleeding Time: Shows that initial platelet plug formation is normal.
• Specific Factor Assays: Confirms low levels of Factor VIII or IX.

Treatment Cornerstone: Factor Replacement Therapy

The primary treatment involves replacing the missing clotting factor. This is done through intravenous infusions of recombinant or plasma-derived factor concentrates. Treatment can be administered “on-demand” in response to a bleed or on a regular “prophylactic” schedule to prevent bleeds.

Complications: The Challenge of Inhibitors

A significant complication is the development of inhibitors—antibodies that the patient’s immune system produces against the infused factor concentrate, neutralizing its effect. Managing patients with inhibitors is complex and requires specialized bypassing agents.

Prophylaxis vs. On-Demand Treatment

Prophylaxis, the regular infusion of factor concentrate to prevent bleeding, is the standard of care for severe hemophilia, especially in children. It aims to maintain a baseline factor level that prevents most spontaneous bleeds, thereby protecting joints and improving quality of life.

Key Takeaways for Exam Day

• Hemophilia A: Factor VIII deficiency. Most common type.
• Hemophilia B: Factor IX deficiency (also called Christmas Disease).
• Inheritance: X-linked recessive, primarily affecting males.
• Lab Profile: Isolated prolonged aPTT with normal PT and platelet count.
• Hallmark Symptom: Hemarthrosis (bleeding into joints).

This content is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.